Biogenesis Bago S.A.
Buenos Aires, Cdad. Autónoma de Buenos Aires
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- Av. Córdoba 950 piso 12 departamento d, C1054 Cdad. Autónoma de Buenos Aires, Argentina
- Website
- biogenesisbago.com
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $3,112,500 |
| FY2024 | -$1 |
| FY2023 | $3,087,500 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Boehringer Ingelheim Animal Health France | Lyon, Auvergne-Rhône-Alpes | 325414 Biological Product (except Diagnostic) Manufacturing |
| Colorado Serum Company | Denver, CO | 325414 Biological Product (except Diagnostic) Manufacturing |
| Innovative Diagnostics | Grabels, Occitanie | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Medgene Labs | Brookings, SD | 325414 Biological Product (except Diagnostic) Manufacturing |
| Kickr Design LLC | — | 541330 Engineering Services |
About the company
Biogenesis Bago S.A. is an Argentina-based for-profit manufacturer of veterinary products registered in the U.S. federal government's System for Award Management (SAM) since 2009. The company specializes in producing vaccines, with a primary focus on foot-and-mouth disease (FMD) vaccines for agricultural and veterinary applications. While specific details about the company's full background are not provided, its federal contract awards demonstrate a significant capability in producing critical veterinary biological products for U.S. government agencies.
The company has been awarded multiple federal contracts exclusively with the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS), specifically through its Marketing and Regulatory Programs Business Services and Veterinary Services divisions. These contracts are uniformly structured as delivery orders for foot-and-mouth disease vaccines, with no set-aside designations. The contract awards range from $1,012,500 to $3,087,500, consistently supporting the National Animal Vaccine and Veterinary Countermeasures Bank program. Each contract involves the procurement of millions of FMD vaccine doses, typically priced around $0.415 per dose, with performance locations in Argentina and completion dates extending through 2034 and 2038.
Biogenesis Bago S.A. holds a significant indefinite delivery contract (IDV) with APHIS, awarded on September 22, 2020, with a potential ceiling value of $100 million through September 2037. This multiple-award IDV is specifically for "BIOGENESIS NAFMDVB FMD VAC AND RELATED ITEMS" and supports task orders for foot-and-mouth disease vaccines. The IDV enables APHIS to strategically maintain vaccine stockpiles and ensure a stable foreign supply of critical veterinary commodities. Associated task orders have been issued with firm fixed pricing, demonstrating the government's commitment to maintaining a consistent and reliable vaccine supply through this Argentine manufacturer.
Quick answers
Is Biogenesis Bago S.A. registered in SAM.gov?
Yes. Biogenesis Bago S.A.'s SAM.gov registration is active through December 9, 2026.
What is Biogenesis Bago S.A.'s CAGE code?
Biogenesis Bago S.A.'s CAGE code is WA229, and its Unique Entity ID (UEI) is RE7GLC5RSVS9.
Which contract vehicles does Biogenesis Bago S.A. hold?
Biogenesis Bago S.A. holds a place on 1 federal contract vehicle: National Animal Vaccine and Veterinary Countermeasures Bank - Foot and Mouth Disease.
How much has Biogenesis Bago S.A. received in federal contracts?
Federal contracts obligated $3,112,500 to Biogenesis Bago S.A. in fiscal year 2025 and $6,199,999 in fiscal years 2023 through 2027.
How does Biogenesis Bago S.A. rank among federal contractors?
Biogenesis Bago S.A. ranked #11 in NAICS 325414, #56 in PSC 6505 and #61 in NAICS 3254 in FY2025.
What is Biogenesis Bago S.A.'s most recent federal award?
Biogenesis Bago S.A.'s most recent federal contract award is BG - nafmdvb purchase biogenesis bago S.A. Contract #: 12639520D0055 QTY 2.5M doses C3 indaial @.415/dose $1,037,500 (12639525F0689), from Marketing and Regulatory Programs Business Services (APHIS), on May 27, 2025.
On GovTribe
See Biogenesis Bago S.A.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors